Assembly Biosciences logo

Assembly Biosciences

Assembly Biosciences (NASDAQ: ASMB) is a clinical-stage biotechnology company committed to bringing finite and curative therapies to the 270 million people living with hepatitis B virus (HBV) worldwide. A pioneer in the development of a new class of potent, oral core inhibitor drug candidates, Assem... Read more

Industries

Employees

51-200

Links


Org chart

Collapse

Board & advisors


Teams


Offices